The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ribociclib (RIBO) + letrozole (LET) in patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC) with no prior endocrine therapy (ET) for ABC: Preliminary results from the phase 3b CompLEEment-1 trial.
 
Michelino DeLaurentiis
Honoraria - AstraZeneca; Celgene; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Celgene; Lilly; Novartis; Pfizer; Roche
 
Patrick Neven
No Relationships to Disclose
 
Guy Heinrich Maria Jerusalem
Honoraria - Amgen; Bristol-Myers Squibb; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Lilly; Novartis; Pfizer; Puma Biotechnology; Roche
Research Funding - Novartis; Roche
Travel, Accommodations, Expenses - Lilly; Novartis; Pfizer; Roche
 
Thomas Denis Bachelot
Consulting or Advisory Role - AstraZeneca; Novartis; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Novartis; pfizer; Roche
 
William Jacot
Honoraria - Pierre Fabre
Consulting or Advisory Role - Pfizer; Roche
Research Funding - AstraZeneca
 
Susan Faye Dent
Honoraria - amgen; Eisai; Roche
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - AstraZeneca; Roche Canada
 
Marco Colleoni
Honoraria - Novartis
Consulting or Advisory Role - AstraZeneca; Celldex; OBI Pharma; Pfizer; Pierre Fabre; Puma Biotechnology
 
Aleix Prat
Consulting or Advisory Role - NanoString Technologies (Inst)
Research Funding - NanoString Technologies (Inst)
 
Miguel Martin
Consulting or Advisory Role - Lilly; Novartis; Pfizer; Roche/Genentech
Research Funding - Novartis (Inst); Roche (Inst)
 
Alistair E. Ring
Honoraria - AstraZeneca; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - Pfizer; Roche
Research Funding - AstraZeneca
 
Paul H. Cottu
Honoraria - AstraZeneca; NanoString Technologies; Novartis; Pfizer; Roche
Consulting or Advisory Role - Novartis; Pfizer; Roche/Genentech
Research Funding - Novartis (Inst); pfizer (Inst)
Travel, Accommodations, Expenses - Novartis; pfizer; Roche
 
Janice M. Lu
Research Funding - NA (Inst)
Travel, Accommodations, Expenses - Novartis
 
Hamdy A. Azim
Employment - Innate Pharma (I)
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Janssen; MSD; Novartis; Pfizer; Roche
Research Funding - Pfizer
 
Katie Zhou
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Jiwen Wu
Employment - Janssen (I); Novartis
Travel, Accommodations, Expenses - Janssen (I)
 
Juan Pablo Zarate
Employment - Novartis
 
Claudio Zamagni
Consulting or Advisory Role - AstraZeneca; Eisai; Novartis; Pfizer; PharmaMar; Pierre Fabre; Roche
Research Funding - Abbvie (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Celgene (Inst); Medivation (Inst); Morphotek (Inst); Novartis (Inst); pfizer (Inst); Roche (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Celgene; Novartis; Pierre Fabre; Roche